Pulmonary pharmacology & therapeutics
Effectiveness of Mepolizumab and Dupilumab in patients with asthma-COPD overlap (ACO) compared to severe uncontrolled asthma (SUA): A retrospective observational cohort study.
Belén Muñoz-Sánchez, Antonio León-Lloreda, David Carlos Echavarría, María Polonio-González, Juan Francisco Medina-Gallardo, Marta Ferrer-Galván, Auxiliadora Romero-Falcón, Javier Díez-Sierra, Francisco Javier Álvarez-Gutiérrez
Published: 202610.1016/j.pupt.2025.102407
Abstract
BACKGROUND: The coexistence of asthma and chronic obstructive pulmonary disease (COPD), known as asthma-COPD overlap (ACO), presents unique diagnostic and therapeutic challenges. Although biological therapies such as Mepolizumab and Dupilumab have tr…
Preview only. Read the full abstract at the source